Related changes
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are shown in bold with a green bullet. See more at Help:Related changes.
List of abbreviations (help):
- D
- Edit made at Wikidata
- r
- Edit flagged by ORES
- N
- New page
- m
- Minor edit
- b
- Bot edit
- (±123)
- Page byte size change
- Temporarily watched page
22 May 2024
- diffhist Genome 21:27 +1,414 Haley275 talk contribs (→Genome-wide reprogramming: Added a brief subsection on genome damage.)
- diffhist Genome 19:31 −81 Genome42 talk contribs (→Coding sequences: Removed incorrect figure (see Talk).)
- diffhist Genome 19:29 −115 Genome42 talk contribs (Removed mispleading figure (see Talk).)
- diffhist Genome 19:24 −1,068 Genome42 talk contribs (→Eukaryotic genomes: Removed unnecessary technical detail.)
- diffhist Genome 19:23 +1,067 Genome42 talk contribs (→Eukaryotic genomes: Removed unnecessary technical detail.) Tag: Manual revert
- diffhist Genome 19:23 −1,067 Genome42 talk contribs (→Eukaryotic genomes: Removed unnecessary technical detail.) Tag: Reverted
- diffhist Genome 12:29 −939 Mindmatrix talk contribs (revert - some of that content is OK, but not inserted in the midst of another paragraph) Tag: Manual revert
- diffhist Genome 09:52 +939 Khushnood Ahmed Shakir talk contribs Tag: Reverted
21 May 2024
- diffhist m Cloning 22:30 +436 Phuzion talk contribs (Reverted edits by RealMrIce (talk): unexplained content removal (HG) (3.4.12)) Tags: Huggle Rollback
- diffhist Amino acid 18:50 −175 DMacks talk contribs (Mostly off-topic, and cut'n'pasted from an uncited source. Undid revision 1224989908 by 139.218.241.100 (talk)) Tag: Undo
- diffhist Amino acid 18:06 +175 139.218.241.100 talk (→Polar charged side chains) Tag: Reverted
- diffhist Naphthalene 11:53 −27 Jni talk contribs (→See also: rm. already linked, was redirect)
20 May 2024
- diffhist Antimicrobial resistance 21:22 +28 Robertpedley talk contribs (→Global action plans and awareness: wikilink) Tag: Visual edit
- diffhist Antimicrobial resistance 21:17 +1,042 Robertpedley talk contribs (→Global action plans and awareness: World Health Organization 2024 Bacterial Priority Pathogens List) Tag: Visual edit
- diffhist m Hepatitis C 10:42 +2 Uhooep talk contribs (→History: case)
19 May 2024
- diffhist m Transfection 07:47 0 Beland talk contribs (change U+00B5 to U+03BC (μ) per Unicode standard and MOS:NUM#Specific units - see Unicode compatibility characters (via WP:JWB))
18 May 2024
- diffhist Food and Drug Administration 19:33 −81 Skm989898 talk contribs
- diffhist m Serine 04:16 −8 Acebulf talk contribs (linkify)
17 May 2024
- diffhist Module:Navbox 21:07 +308 Izno talk contribs (per Template talk:Navbox#Night mode may need explicit color definitions)
- diffhist Hepatitis C 15:40 +4 79.49.205.48 talk (#article-section-source-editor) Tags: Mobile edit Mobile app edit iOS app edit
- diffhist Merck & Co. 15:23 −49 Willondon talk contribs (revert last 2 edits; unsourced) Tag: Undo
- diffhist Imidazole 13:52 +184 2a0c:5bc0:40:10e8:5265:f3ff:fe2e:6ade talk (→Use in biological research)
- diffhist Merck & Co. 12:42 +26 Lixland talk contribs Tags: Reverted Visual edit Mobile edit Mobile web edit
- diffhist Merck & Co. 09:44 +23 Lixland talk contribs Tags: Manual revert Reverted Visual edit Mobile edit Mobile web edit
- diffhist Merck & Co. 09:26 −23 Sam Sailor talk contribs (Undid revision 1217037793 by Lixland (talk), rvv) Tags: Undo Reverted
16 May 2024
- diffhist Half-life 15:12 −161 2a0c:5bc0:40:1a05:4174:63df:1601:31b1 talk (→Examples: Given the image and caption it is not immediately clear how it relates to the article. Furthermore, following the link on the caption leads to a Wikiversity article that is incomplete and also fails to explain how the presented image relates to half-life.) Tag: Visual edit: Switched
- diffhist Discovery and development of NS5A inhibitors 15:08 +6 152.132.9.192 talk (→History: This statement is in error "NS5A inhibitors have been found particularly effective in the treatment of HCV where they have been used in combination with other protease inhibitors such as NS5B inhibitors (e.g. sofosbuvir)" Edited to "NS5A inhibitors have been found particularly effective in the treatment of HCV where they have been used in combination with NS3/4 protease inhibitors such as glecaprevir or NS5B inhibitors (e.g., sofosbuvir), ")